Executive Director, Biostatistics Exelixis Inc.Executive Director, BiostatisticsAlameda, CA$271,000–$385,000 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of 16 years of related experience; or, PhD in Statistics/Biostatistics or related discipline and a minimum of 15 years of related experience; or, Equivalent combination of education and relevant experience in oncology. SUMMARY/JOB PURPOSE: Leads the biostatistics function in developing statistical strategy, design, and analyses for conducting clinical trials in all phases for multiple compounds.
Sr Director, Biostatistics Exelixis Inc.Sr Director, BiostatisticsAlameda, CA$248,000–$352,500 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of 13 years of related experience; or, PhD in Statistics/Biostatistics or related discipline and a minimum of 12 years of related experience; or, Equivalent combination of education and relevant experience in oncology. SUMMARY/JOB PURPOSE: Provides leadership to the biostatistics function and direct management of biostatistics staff in developing statistical strategy, design, and analyses for clinical trials for multiple compounds with a focus on early phase (1/2) trials.
NewSenior Scientist, Clinical Biostatistics & Genetic Risk Prediction MyOmeSenior Scientist, Clinical Biostatistics & Genetic Risk PredictionSan Francisco, CA$160,000–$180,000 / yearThis is a key role on a small, self-sufficient, and versatile team: the successful candidate will roll up their sleeves to deliver the analysis end-to-end, transforming ambiguous questions into defensible, reproducible, and impactful findings. We're seeking a senior scientist with a strong background in clinical statistics and human genetics to design and analyze the clinical studies that establish the utility of our risk prediction models in real clinical settings.
Associate Biostatistics Director Exelixis Inc.Associate Biostatistics DirectorAlameda, CA$166,500–$236,500 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: MS/MA degree in related discipline and a minimum of 9 years of related experience; or, PhD in related discipline and a minimum of 5 years of related experience; or, Equivalent combination of education and experience. Works collaboratively with clinicians, data managers, biostatisticians, statistical programmers, and medical writers in the planning, conduct and analysis of clinical trials.
Vice President, Biostatistics Exelixis Inc.Vice President, BiostatisticsAlameda, CA$360,000–$418,000 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: BA/BS in related discipline and a minimum of twenty-one years of relevant experience in the pharmaceutical industry; or, MA/MS in related discipline and a minimum of nineteen years of relevant experience in the pharmaceutical industry; or, PhD in related discipline and a minimum of seventeen years of relevant experience in the pharmaceutical industry; or, Equivalent combination of education and experience. ESSENTIAL DUTIES AND RESPONSIBILITIES: In collaboration with the product development teams and through subordinate management, leads the effective development and implementation of strategies consistent with the company's strategic objectives, and ensures the overall effective operations of the biostatistics, and Biostatistics associated tools and processes.
Director, Biostatistics Summit Therapeutics plcDirector, BiostatisticsPalo Alto, CAOverview of Role: Serves as the project level biostatistician and provides leadership within biostatistics function to develop and execute statistical strategy, study design, statistical analyses, and regulatory submissions for clinical trials in oncology. Experience, Education and Specialized Knowledge and Skills: PhD and a minimum of 8+ years of experience or Masters (MS) and a minimum of 11+ years of experience in statistics or biostatistics or related disciplines with clinical trials, pharmaceutical/biotech industry, or healthcare experience.
Director, Biostatistics TempusDirector, BiostatisticsRedwood City, CA$180,000–$240,000 / yearWe are seeking a highly motivated and capable Director of Biostatistics to lead a team of biostatisticians involved in multiple aspects of clinical research at Tempus. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Biostatistics Epidemiologist - Fully Remote MercorBiostatistics Epidemiologist - Fully RemoteSan Francisco, CaliforniaRemote$175–$275 / hourFor details about the interview process and platform information, please check: https://talent.docs.mercor.com/welcome. Create and critique rubrics that analyze commercial drugs and drug-development programs.
Associate Director, Biostatistics Summit Therapeutics plcAssociate Director, BiostatisticsPalo Alto, CAReview the accuracy of clinical data, perform statistical analysis, ensure the application of appropriate statistical methods, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final clinical study reports. Partners with cross-functional team members in ensuring accuracy/consistency of clinical data and exceptional delivery, interpretation of clinical results, and assists in the development and review of regulatory submission documents.
Sr. Director, Biostatistics ALX Oncology Inc.Sr. Director, BiostatisticsSouth San Francisco, CA$240,000Approximately 12+ years of progressive Biostatistics experience within biotechnology, pharmaceutical, or CRO environments, including Phase I-III oncology clinical studies, with demonstrated success leading statistical strategy for registrational clinical trials, partnering across cross-functional teams, and supporting global regulatory submissions. The Senior Director, Biostatistics provides strategic statistical leadership across ALX Oncology's clinical development portfolio, partnering cross-functionally to design, execute, analyze, and interpret clinical studies that support regulatory submissions and advance innovative oncology therapies.
Associate Director, Biostatistics Clinical Late Stage Revolution Medicines, Inc.Associate Director, Biostatistics Clinical Late StageRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, Biostatistics, Late Clinical Stage Revolution Medicines, Inc.Director, Biostatistics, Late Clinical StageRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and studies in clinical late-stage development and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Director, Biostatistics, Early Phase Revolution Medicines, Inc.Director, Biostatistics, Early PhaseRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Biostatistics Corcept TherapeuticsAssociate Director, BiostatisticsRedwood City, CA$183,500–$269,800 / yearWith advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. The pay range that the Company reasonably expects to pay for this headquarters-based position is $183,500 - $269,800; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Senior Manager, Biostatistics Corcept TherapeuticsSenior Manager, BiostatisticsRedwood City, CA$165,150–$242,820 / yearWith advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. The pay range that the Company reasonably expects to pay for this headquarters-based position is $165,150 - $242,820; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Senior Manager, Biostatistics Bristol Myers SquibbSenior Manager, BiostatisticsBrisbane, CA$188,730–$228,701 / yearBased on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day. Each of us is empowered to apply our individual talents and unique perspectives in a supportive culture, promoting global participation in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Associate Director, Biostatistics Clinical Late Stage Revolution MedicinesAssociate Director, Biostatistics Clinical Late StageRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, Biostatistics, Late Clinical Stage Revolution MedicinesDirector, Biostatistics, Late Clinical StageRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Playing a critical role as a lead statistician for clinical program(s) and studies in clinical late-stage development and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Director, Biostatistics, Early Phase Revolution MedicinesDirector, Biostatistics, Early PhaseRedwood City, CaliforniaLeveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
NewSr Biostatistics Director Exelixis IncSr Biostatistics DirectorAlameda, CA$216,500–$307,500 / yearEDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: BS/BA degree in Statistics/Biostatistics or related discipline and a minimum of fifteen years of related experience; or, MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of thirteen years of related experience; or, PhD in Statistics/Biostatistics or related discipline and a minimum of twelve years of related experience, or; Equivalent combination of education and experience. Knowledge/Skills: Comprehensive and detailed knowledge of: statistical experimental designs, analyses and clinical trial requirements, particularly pertaining to oncology trials.